Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

5HT3 Antagonism and Auditory Gating in Schizophrenia

NCT00018850 is registered in ClinicalTrials.gov with US Department of Veterans Affairs as lead sponsor.

NCT NCT00018850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00018850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
5HT3 Antagonism and Auditory Gating in Schizophrenia
Lead sponsor
US Department of Veterans Affairs
Phase
Not applicable
Overall status
Completed
Start date
June 30, 1998
Completion date
June 30, 2003
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia